Abstract: Revised 2/22/2022 ; "The purpose of this document is to provide guidance to health care providers on the use of therapeutics to treat COVID-19 positive individuals, as well as pre-exposure prophylaxis for immunocompromised individuals"--page 1.
No Comments.